Bank of America’s Asterias Biotherapeutics Inc. Series A AST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-436
| Closed | – | – | 7766 |
|
|
2018
Q4 | $0 | Sell |
436
-57
| -12% | -$59 | ﹤0.01% | 7763 |
|
|
2018
Q3 | $1K | Sell |
493
-20,404
| -98% | -$31.7K | ﹤0.01% | 7220 |
|
|
2018
Q2 | $28K | Buy |
20,897
+17,878
| +592% | +$27.4K | ﹤0.01% | 6406 |
|
|
2018
Q1 | $5K | Sell |
3,019
-1,211
| -29% | -$2.53K | ﹤0.01% | 6788 |
|
|
2017
Q4 | $10K | Buy |
4,230
+2,228
| +111% | +$5.64K | ﹤0.01% | 6625 |
|
|
2017
Q3 | $6K | Buy |
2,002
+699
| +54% | +$2.35K | ﹤0.01% | 6710 |
|
|
2017
Q2 | $4K | Sell |
1,303
-3,568
| -73% | -$11.8K | ﹤0.01% | 6661 |
|
|
2017
Q1 | $17K | Buy |
4,871
+891
| +22% | +$3.46K | ﹤0.01% | 6382 |
|
|
2016
Q4 | $19K | Buy |
3,980
+2,072
| +109% | +$8.55K | ﹤0.01% | 6374 |
|
|
2016
Q3 | $8K | Buy |
1,908
+627
| +49% | +$2.03K | ﹤0.01% | 6478 |
|
|
2016
Q2 | $3K | Sell |
1,281
-377
| -23% | -$1.36K | ﹤0.01% | 6871 |
|
|
2016
Q1 | $8K | Sell |
1,658
-305
| -16% | -$1.18K | ﹤0.01% | 6466 |
|
|
2015
Q4 | $7K | Buy |
1,963
+126
| +7% | +$581 | ﹤0.01% | 6812 |
|
|
2015
Q3 | $7K | Sell |
1,837
-369
| -17% | -$1.7K | ﹤0.01% | 6696 |
|
|
2015
Q2 | $10K | Buy |
2,206
+148
| +7% | +$1.42K | ﹤0.01% | 6612 |
|
|
2015
Q1 | $14K | Buy |
2,058
+49
| +2% | +$243 | ﹤0.01% | 6205 |
|
|
2014
Q4 | $7K | Buy |
+2,009
| New | +$8.09K | ﹤0.01% | 7206 |
|
Bank of America's AST Position: Q1 2019 in Review
Bank of America sold out of Asterias Biotherapeutics Inc. Series A (AST) in Q1 2019, closing a stake of 436 shares.
Bank of America first reported a position in AST in Q4 2014 and held it in 17 quarters. The position peaked at $28K in Q2 2018. 0 funds tracked by Wall St. Rank hold AST as of Q1 2019.
- Bank of America reported no remaining Asterias Biotherapeutics Inc. Series A position as of Q1 2019 after selling out during the quarter.
- Bank of America sold 436 Asterias Biotherapeutics Inc. Series A shares in Q1 2019.
- Bank of America first reported a position in Asterias Biotherapeutics Inc. Series A in Q4 2014 and held it in 17 quarters.
- Bank of America's Asterias Biotherapeutics Inc. Series A position peaked at $28K in Q2 2018.
- 0 funds tracked by Wall St. Rank held Asterias Biotherapeutics Inc. Series A as of Q1 2019.
Based on Bank of America's 13F filing for Q1 2019, filed 15 May 2019.